General Internal Medicine PatientsNCT00195130
Prognostic Measures in Ambulatory Care Settings
An observational study of General Internal Medicine Patients, run by Weill Medical College of Cornell University at 1 site in United States.
Trial summary
The primary objective of this prospective study is to develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity (including the deterioration of pre-existing conditions or development of new problems) and functional… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- General Internal Medicine Patients
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 2,000 participants
- Where
- 1 siteUnited States
- Study dates
- Jan 1998to Jan 1999
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- 1. Patients who are currently under the care of Physicians at Cornell Internal Medicine Associates.
Who cannot join
- Patients who do not wish to participate in the study.
- Patients who are not able to provide informed written consent.
Trial locations and contacts
1 site in 1 country.
United States1 site
New York Presbyterian Hospital-Weill Cornell Medical College
New York, New York, 10065
About this study
The primary objective of this prospective study is to develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity (including the deterioration of pre-existing conditions or development of new problems) and functional deterioration.
Read the detailed description
Specifically, from a random sample of 2000 patients taken from a cohort of established patients followed for at least three years in a general medicine practice, the objectives are:
- to identify the demographic, clinical, and functional status variable that predict the risk of death, morbid events (e.g., the development of new complications or deterioration of existing conditions), or the deterioration in functional status using a half of the cohort chosen at random;
- to combine these findings into a prognostic scale that can be employed in routine clinical practice; and
- to validate the performance of this scale in the second half of the cohort.
There are no interventions in this study. Patients already under medical care by Cornell physicians will be enrolled. The only requirements for patients are to complete the questionnaires on an annual basis.
- Conditions
- General Internal Medicine Patients
- Being tested
- There are no interventions in this study
- Keywords
- prognosis, risk of death, morbidity, mortality, quality of life
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
There are no interventions in this studyBehavioural
What is being measured
The primary outcome is the main question the study is designed to answer.
To develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity and functional deterioration.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Sep 2005 (estimated)
- Study startJan 1998
- Study completionJan 1999
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for General Internal Medicine PatientsStudies of the same condition, open and under way.
- More trials run by Weill Medical College of Cornell UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Enrolment
- 2,000 participants
Sponsor and investigators
- Lead sponsor
- Weill Medical College of Cornell University
- Sponsor type
- University, hospital or other
- Investigators
- Mary E Charlson, MD, Principal investigator, Weill Medical College at Cornell University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00195130
- Sponsor's protocol ID
- 0397-727
- Status last verified
- Mar 2008
- First submitted
- 15 Sep 2005
- Last updated
- 28 Mar 2008
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 28 Mar 2008. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prognostic Measures in Ambulatory Care Settings
- ClinicalTrials.gov ID
- NCT00195130
- Acronym / sponsor ID
- 0397-727
- Conditions
- General Internal Medicine Patients
- Keywords
- prognosis, risk of death, morbidity, mortality, quality of life
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 2,000 participants
- Lead sponsor
- Weill Medical College of Cornell UniversityUniversity, hospital or other
- Study start
- Jan 1998
- Study completion
- Jan 1999
- First posted
- 19 Sep 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The primary objective of this prospective study is to develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity (including the deterioration of pre-existing conditions or development of new problems) and functional deterioration.
Detailed description
Specifically, from a random sample of 2000 patients taken from a cohort of established patients followed for at least three years in a general medicine practice, the objectives are:
- to identify the demographic, clinical, and functional status variable that predict the risk of death, morbid events (e.g., the development of new complications or deterioration of existing conditions), or the deterioration in functional status using a half of the cohort chosen at random;
- to combine these findings into a prognostic scale that can be employed in routine clinical practice; and
- to validate the performance of this scale in the second half of the cohort.
There are no interventions in this study. Patients already under medical care by Cornell physicians will be enrolled. The only requirements for patients are to complete the questionnaires on an annual basis.
Study design
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- 1. Patients who are currently under the care of Physicians at Cornell Internal Medicine Associates.
Key exclusion criteria (2 listed)
- Patients who do not wish to participate in the study.
- Patients who are not able to provide informed written consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| There are no interventions in this study | Behavioural | – |
Primary outcome
To develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity and functional deterioration.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Mar 2008.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Mary E Charlson, MD principal investigator
Weill Medical College at Cornell University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of General Internal Medicine Patients, run by Weill Medical College of Cornell University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 28 Mar 2008. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To develop a new method of classifying the prognosis of ambulatory patients according to their risk of long term mortality, institutionalization, morbidity and functional deterioration.. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Mar 2008; AzTrials last refreshed its copy on 3 Nov 2026.